← Back to Search
Independent β-arrestin 2 And G Protein-mediated Pathways For Angiotensin II Activation Of Extracellular Signal-regulated Kinases 1 And 2
Huijun Wei, Seungkirl Ahn, S. Shenoy, S. Karnik, L. Hunyady, L. Luttrell, R. Lefkowitz
Published 2003 · Biology
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Stimulation of a mutant angiotensin type 1A receptor (DRY/AAY) with angiotensin II (Ang II) or of a wild-type receptor with an Ang II analog ([sarcosine1,Ile4,Ile8]Ang II) fails to activate classical heterotrimeric G protein signaling but does lead to recruitment of β-arrestin 2-GFP and activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) (maximum stimulation ≈50% of wild type). This G protein-independent activation of mitogen-activated protein kinase is abolished by depletion of cellular β-arrestin 2 but is unaffected by the PKC inhibitor Ro-31-8425. In parallel, stimulation of the wild-type angiotensin type 1A receptor with Ang II robustly stimulates ERK1/2 activation with ≈60% of the response blocked by the PKC inhibitor (G protein dependent) and the rest of the response blocked by depletion of cellular β-arrestin 2 by small interfering RNA (β-arrestin dependent). These findings imply the existence of independent G protein- and β-arrestin 2-mediated pathways leading to ERK1/2 activation and the existence of distinct “active” conformations of a seven-membrane-spanning receptor coupled to each.
This paper references
Discrete amino acid sequences of the alpha 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis.
S. Cotecchia (1992)
Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways.
K. Crawford (1992)
Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors.
J. Pitcher (1992)
Modulation of GDP Release from Transducin by the Conserved Glu134-Arg135 Sequence in Rhodopsin*
S. Acharya (1996)
The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization.
S. Laporte (1996)
Angiotensin II activates mitogen-activated protein kinase via protein kinase C and Ras/Raf-1 kinase in bovine adrenal glomerulosa cells.
Y. Tian (1998)
Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.
L. Luttrell (1999)
Differential Affinities of Visual Arrestin, βArrestin1, and βArrestin2 for G Protein-coupled Receptors Delineate Two Major Classes of Receptors*
R. Oakley (2000)
The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex.
K. Defea (2000)
Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation.
A. Scheer (2000)
The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists.
C. Watson (2000)
Arrestin Binding to the G Protein-coupled N-Formyl Peptide Receptor Is Regulated by the Conserved “DRY” Sequence*
T. A. Bennett (2000)
The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor.
A. Alewijnse (2000)
β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2
K. Defea (2000)
Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.
P. McDonald (2000)
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
T. Kenakin (2001)
Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking.
W. Miller (2001)
Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds
L. Luttrell (2001)
New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades
K. L. Pierce (2001)
Signaling at zero G: G-protein-independent functions for 7-TM receptors.
J. Brzostowski (2001)
Targeting of Cyclic AMP Degradation to β2-Adrenergic Receptors by β-Arrestins
S. Perry (2002)
Regulation of G protein-coupled receptor signaling by scaffold proteins.
R. A. Hall (2002)
Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors.
Alice C Holloway (2002)
β-Arrestin Scaffolding of the ERK Cascade Enhances Cytosolic ERK Activity but Inhibits ERK-mediated Transcription following Angiotensin AT1a Receptor Stimulation*
A. Tohgo (2002)
AT1 Receptor Mutant Lacking Heterotrimeric G Protein Coupling Activates the Src-Ras-ERK Pathway without Nuclear Translocation of ERKs*
K. Seta (2002)
The Stability of the G Protein-coupled Receptor-β-Arrestin Interaction Determines the Mechanism and Functional Consequence of ERK Activation*
A. Tohgo (2003)
Structural determinants for the activation mechanism of the angiotensin II type 1 receptor differ for phosphoinositide hydrolysis and mitogen-activated protein kinase pathways.
J. Hines (2003)
The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling.
Z. Gáborik (2003)
Keeping G Proteins at Bay: A Complex Between G Protein-Coupled Receptor Kinase 2 and Gßγ
D. Lodowski (2003)
Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference
Seungkirl Ahn (2003)
This paper is referenced by
Lock, Stock and Barrel: Role of Renin-Angiotensin-Aldosterone System in Coronavirus Disease 2019
C. Zanza (2021)
Conceptual and experimental issues in biased agonism.
H. O. Onaran (2021)
Anti-ATR001 monoclonal antibody ameliorates atherosclerosis through beta-arrestin2 pathway.
Yingxuan Wang (2021)
Vasopressin V2 is a promiscuous G protein-coupled receptor that is biased by its peptide ligands
F. Heydenreich (2021)
G protein- and β-arrestin Signaling Profiles of Endothelin Derivatives at the Type A Endothelin Receptor
Xinyu Xiong (2021)
Chimeric GPCRs mimic distinct signaling pathways and modulate microglia responses
R. Schulz (2021)
Mechanistic diversity involved in the desensitization of G protein-coupled receptors.
Ningning Sun (2021)
Blocking FcγRIIB in Smooth Muscle Cells Reduces Hypertension
Xiaomin Song (2021)
Receptors | Angiotensin Receptors
Triveni R Pardhi (2021)
β-Arrestins and Endocrine-Related GPCRs
Francesco De Pascali (2021)
Opposing functions of β-arrestin 1 and 2 in Parkinson’s disease via microglia inflammation and Nprl3
Yinquan Fang (2021)
Overexpression of β-Arrestins inhibits proliferation and motility in triple negative breast cancer cells
Saber Yari Bostanabad (2021)
The LPA3 Receptor: Regulation and Activation of Signaling Pathways
K. H. Solís (2021)
Modulation of the rat angiotensin type 1a receptor by an upstream short open reading frame
Parnika S Kadam (2021)
Arrestin-dependent and -independent internalization of GPCRs-methods, mechanisms and implications on cell signaling
Ee Von Moo (2021)
Pharmacology of T2R Mediated Host-Microbe Interactions.
M. Medapati (2021)
Mixture interactions at mammalian olfactory receptors are dependent on the cellular environment
E. Corey (2021)
The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles
Yunlu Jiang (2021)
An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update
Kanika Verma (2021)
Beta-arrestins operate an on/off control switch for focal adhesion kinase activity
R. Alexander (2020)
Functional anatomy of the full length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis
Bryan S. Stephens (2020)
The Potential of 19F NMR Application in GPCR Biased Drug Discovery.
Xudong Wang (2020)
A kinetic method for measuring agonist efficacy and ligand bias using high resolution biosensors and a kinetic data analysis framework
S. Hoare (2020)
Myogenic Vasoconstriction Requires Canonical Gq/11 Signaling of the Angiotensin II Type 1a Receptor in the Murine Vasculature
Yingqiu Cui (2020)
Cell active and functionally-relevant small-molecule agonists of calcitonin receptor.
Shuai Zhao (2020)
Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
L. Vasudevan (2020)
Crystal Structure of β-Arrestin 2 in Complex with CXCR7 Phosphopeptide.
K. Min (2020)
Key phosphorylation sites in GPCRs orchestrate the contribution of β‐Arrestin 1 in ERK1/2 activation
Mithu Baidya (2020)
β-Arrestin-Biased Agonist Targeting the Brain AT1R (Angiotensin II Type 1 Receptor) Increases Aversion to Saline and Lowers Blood Pressure in Deoxycorticosterone Acetate-Salt Hypertension.
M. Zanaty (2020)
Biased agonism at the cannabinoid receptors - Evidence from synthetic cannabinoid receptor agonists.
Monica Patel (2020)
Angiotensin II receptors
K. D. Singh (2020)
Dopamine receptors in emesis: molecular mechanisms and potential therapeutic function.
L. Belkacemi (2020)See more